Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data

by Florian Kirsch, Christian Becker, Christoph Kurz, Lars Schwettmann, Anja Schramm
Published 2020-12-01

Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life

by Manuel B. Huber, Nelli Schneider, Florian Kirsch, Larissa Schwarzkopf, Anja Schramm, Reiner Leidl
Published 2021-08-01

The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data

by Manuel B. Huber, Christoph Kurz, Florian Kirsch, Larissa Schwarzkopf, Anja Schramm, Reiner Leidl
Published 2020-11-01

Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study

by Florian Kirsch, Anja Schramm, Larissa Schwarzkopf, Johanna I. Lutter, Boglárka Szentes, Manuel Huber, Reiner Leidl
Published 2019-10-01